These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 16596312)
41. Breast cancer risk in postmenopausal women using estrogen-only therapy. Lyytinen H; Pukkala E; Ylikorkala O Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766 [TBL] [Abstract][Full Text] [Related]
42. Report: prostate cancer, breast cancer leading newly diagnosed cancers. FDA Consum; 2005; 39(1):7. PubMed ID: 15803586 [No Abstract] [Full Text] [Related]
43. The darkness at the end of the tunnel: summary and evaluation of an international symposium on light, endocrine systems and cancer. Poole C Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():71-8. PubMed ID: 12163852 [TBL] [Abstract][Full Text] [Related]
44. Does light cause internal cancers? The problem and challenge of an ubiquitous exposure. Erren TC Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():61-70. PubMed ID: 12163851 [TBL] [Abstract][Full Text] [Related]
45. U.S. cancer incidence: prostate cancer and breast cancer are most common. J Environ Health; 2004 Mar; 66(7):61, 63. PubMed ID: 15032116 [No Abstract] [Full Text] [Related]
46. Endocrine aspects of breast and prostatic cancer: an overview. Bulbrook RD Cancer Surv; 1986; 5(3):435-45. PubMed ID: 3555776 [No Abstract] [Full Text] [Related]
47. Prostatic carcinoma in Egypt: epidemiology and etiology. Sherif M; Ibrahim AS; El-Aaser AA Scand J Urol Nephrol Suppl; 1980; 55():25-6. PubMed ID: 6938031 [TBL] [Abstract][Full Text] [Related]
48. Aspartame and breast and other cancers. Schwartz GR West J Med; 1999; 171(5-6):300-1. PubMed ID: 10639863 [No Abstract] [Full Text] [Related]
49. [Quantitative analysis of mechanical characteristics of pathologically altered soft biological tissues]. Skovorda AR; Klishko AN; Gusakian DA; Maevskiĭ EI; Ermilova VD; Oranskaia GA; Sarvazian AP Biofizika; 1995; 40(6):1335-40. PubMed ID: 8590726 [TBL] [Abstract][Full Text] [Related]
52. Protective role of melatonin in breast cancer: what we can learn from women with blindness. Minella C; Coliat P; Amé S; Neuberger K; Stora A; Mathelin C; Reix N Cancer Causes Control; 2022 Jan; 33(1):1-13. PubMed ID: 34837156 [TBL] [Abstract][Full Text] [Related]
53. Age-specific acceleration of cancer. Frank SA Curr Biol; 2004 Feb; 14(3):242-6. PubMed ID: 14761658 [TBL] [Abstract][Full Text] [Related]
56. Light pollution as a factor in breast and prostate cancer. Lamphar H; Kocifaj M; Limón-Romero J; Paredes-Tavares J; Chakameh SD; Mego M; Prado NJ; Baez-López YA; Diez ER Sci Total Environ; 2022 Feb; 806(Pt 4):150918. PubMed ID: 34653461 [TBL] [Abstract][Full Text] [Related]
57. A discussion of breast cancer. ADAIR FE N Y State J Med; 1959 Jun; 59(11):2149-53. PubMed ID: 13657366 [No Abstract] [Full Text] [Related]
58. Reduced cancer incidence among the blind. Feychting M; Osterlund B; Ahlbom A Epidemiology; 1998 Sep; 9(5):490-4. PubMed ID: 9730026 [TBL] [Abstract][Full Text] [Related]
59. Night shift work and female breast cancer: a two-stage dose-response meta-analysis for the correct risk definition. Moon J; Ikeda-Araki A; Mun Y BMC Public Health; 2024 Jul; 24(1):2065. PubMed ID: 39085800 [TBL] [Abstract][Full Text] [Related]
60. Risk of prostate cancer with increasing years of night shift work: A two-stage dose-response meta-analysis with duration of night shift work as exposure dose. Moon J; Holzhausen EA; Mun Y Heliyon; 2024 Apr; 10(8):e29080. PubMed ID: 38628771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]